robert dreicer, md, provides results presented concerning psma-linked 177lutethium regarding mcrpc
Published 4 years ago • 25 plays • Length 2:09
Download video MP4
Download video MP3
Similar videos
-
2:34
robert dreicer, md, on the utilization of psma pet scanning & biomarkers in prostate cancer
-
2:05
robert dreicer, md, describes the results of the javelin-100 bladder cancer trial
-
2:00
robert dreicer, md, updates us on the role of cabazitaxel from the card study
-
3:01
preliminary findings in mcrpc for fractionated dose 177lu-psma-617
-
0:57
real-world outcomes of 177lu-psma-617 in mcrpc
-
11:07
phase 3 vision study of 177lupsma 617 for metastatic castration-resistant prostate cancer
-
11:58
lutetium-177, diet, prostatitis, and bph | answering youtube comments #1 | mark scholz, md
-
13:31
radiation, psma, immune therapy | questions from the pcri mid-year update | mark scholz, md
-
1:46:33
how to use prostate-specific membrane antigen-positron emission tomography/ct (2024)
-
6:03
prostate-specific membrane antigen activated prodrug and imaging agents
-
3:17
the relationship between prostate cancer treatment efficacy, survival and race | robert dreicer
-
0:52
dr. robert dreicer on potential combinations in prostate cancer
-
0:50
dr. dreicer on future treatment approaches in prostate cancerdreicer
-
3:56
vision: 177lu-psma-617 in psma-positive mcrpc
-
2:18:25
prostate imaging: mris & psma | steven raman, md & mark moyad, md, mph | #pcri #prostatecancer
-
2:37
therap: cabazitaxel versus 177lu-psma-617 for mcrpc
-
1:22
treatment for advanced prostate cancer patients | lutetium 177 psma radioligand therapy | mercy
-
2:13
implications on prostate-specific membrane antigen (psma) targeted therapy
-
2:56
therap: lupsma versus cabazitaxel for prostate cancer
-
2:18
eleni efstathiou, md, phd, discusses the prostate-specific membrane antigen (psma) lutetium
Clip.africa.com - Privacy-policy